Moreover, high levels of CYP26A1 expression and RA catabolic activity have been detected in breast epithelial adenocarcinoma tissue culture, head and neck cancer squamous cells, and acute promyelocytic leukemia cells [33,34]. This evidence concerns the gene CYP26A1 and head and neck cancer.